Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interstitial lung disease with a rash and autoimmunity.
Roux C, Dupin N, Marey J, Sohier P, Charpentier MC. Roux C, et al. Among authors: dupin n. Respir Med Res. 2023 Nov;84:101029. doi: 10.1016/j.resmer.2023.101029. Epub 2023 May 24. Respir Med Res. 2023. PMID: 37619427 No abstract available.
Non eosinophilic chronic stricturing esophagitis: Lessons from thirty eight cases.
Marin FS, Assaf A, Oumrani S, Seta V, Gaudric M, Beuvon F, Belle A, Coriat R, Dupin N, Chaussade S, Barret M. Marin FS, et al. Among authors: dupin n. Clin Res Hepatol Gastroenterol. 2023 Oct;47(8):102202. doi: 10.1016/j.clinre.2023.102202. Epub 2023 Aug 30. Clin Res Hepatol Gastroenterol. 2023. PMID: 37657720
Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, Bettuzzi T, Chasset F, Descamps V, Deschamps L, Mahevas M, Terrier B, Sohier P, Guegan S, Kramkimel N, Darbord D, Chanal J, Oulès B, Aractingi S, Seta V, Dupin N. Cohen E, et al. Among authors: dupin n. Eur J Dermatol. 2023 Dec 1;33(6):680-685. doi: 10.1684/ejd.2023.4584. Eur J Dermatol. 2023. PMID: 38465550
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrede-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Reference Center for Autoimmune Blistering Diseases MALIBUL. Tedbirt B, et al. Among authors: dupin n. JAMA Dermatol. 2024 Mar 1;160(3):290-296. doi: 10.1001/jamadermatol.2023.5679. JAMA Dermatol. 2024. PMID: 38265821 Clinical Trial.
Evaluation of the usefulness of routine molecular biology for the diagnosis of primary syphilis by assessing the serological status of patients with PCR-confirmed syphilitic ulcers.
Hembert R, Salle R, Grange PA, Ollagnier G, Benhaddou N, Heller U, Saule J, Del Giudice P, Fouéré S, Bertolotti A, Dupin N. Hembert R, et al. Among authors: dupin n. J Eur Acad Dermatol Venereol. 2023 Dec 22. doi: 10.1111/jdv.19761. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 38131606 No abstract available.
474 results